|
GTF2E2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.34590125103296E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.52630147304467E-11 |
| Normal-vs-Stage2 |
1.57486999999845E-05 |
| Normal-vs-Stage3 |
1.15389999999493E-07 |
| Normal-vs-Stage4 |
1.269670E-02 |
| Stage1-vs-Stage2 |
7.303600E-01 |
| Stage1-vs-Stage3 |
1.925890E-02 |
| Stage1-vs-Stage4 |
4.853200E-01 |
| Stage2-vs-Stage3 |
1.491370E-01 |
| Stage2-vs-Stage4 |
6.878800E-01 |
| Stage3-vs-Stage4 |
5.119000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74538161701321E-12 |
| Normal-vs-AfricanAmerican |
4.38540004310539E-09 |
| Normal-vs-Asian |
8.364200E-02 |
| Caucasian-vs-AfricanAmerican |
4.042600E-01 |
| Caucasian-vs-Asian |
1.333780E-02 |
| AfricanAmerican-vs-Asian |
1.533010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.49298368007567E-12 |
| Normal-vs-Female |
1.49889989309315E-10 |
| Male-vs-Female |
1.557760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.70560000023868E-07 |
| Normal-vs-Extreme_Weight |
5.48228129559902E-12 |
| Normal-vs-Obese |
3.3131053456259E-11 |
| Normal-vs-Extreme_Obese |
2.492500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.450600E-01 |
| Normal_Weight-vs-Obese |
3.770600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.376000E-01 |
| Extreme_Weight-vs-Obese |
8.602000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.027000E-01 |
| Obese-vs-Extreme_Obese |
1.671550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.165600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.7054135881267E-12 |
| Normal-vs-Age(61-80Yrs) |
1.87370008397636E-10 |
| Normal-vs-Age(81-100Yrs) |
9.9905999999983E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.484800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.995500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.969700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.963830E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.550400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.171200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.2412072198108E-12 |
| Normal-VS-Type2 PRCC |
4.5877999999E-07 |
| Normal-VS-KIRP CIMP |
3.84730000000388E-05 |
| Normal-VS-Unclassified PRCC |
8.08500000000212E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.820200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.01820000051067E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.893000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.04229999999361E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.326200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.807600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63940000019736E-07 |
| Normal-vs-N1 |
5.85150000009804E-07 |
| Normal-vs-N2 |
3.38273853373039E-12 |
| N0-vs-N1 |
9.328400E-02 |
| N0-vs-N2 |
5.754700E-04 |
| N1-vs-N2 |
1.086230E-02 |
|
|
